MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 1705339 CAUSEWAY BAY, K3

Position in CRBP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,422,382

-$84,356 QoQ

Shares Held

151,640

-5.5% QoQ

Ownership

0.784%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 106 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $446,316,962 across 286 Biotechnology names. CRBP ranks #66 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	150,692	$74,853,236
2	REGN	Regeneron Pharmaceuticals, Inc.	59,595	$37,159,864
3	ALNY	Alnylam Pharmaceuticals, Inc.	63,265	$19,044,662
4	RPRX	Royalty Pharma plc	259,390	$14,543,997
5	TWST	Twist Bioscience Corp	100,108	$10,299,110
6	INCY	Incyte Corp	83,084	$9,418,401
7	PRAX	Praxis Precision Medicines, Inc.	27,185	$9,101,265
8	MRNA	Moderna, Inc.	106,564	$7,462,676

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,422,382	151,640	-5.5%	Shares	Defined	2026-08-14
2026-03-31	$1,506,738	160,462	-11.9%	Shares	Defined	2026-05-15
2025-12-31	$1,481,984	182,062	+112.1%	Shares	Defined	2026-02-17
2025-09-30	$1,085,698	85,826	-27.9%	Shares	Defined	2025-11-14
2025-06-30	$821,486	119,056	-7.7%	Shares	Defined	2025-08-14
2025-03-31	$685,217	129,043	-20.8%	Shares	Defined	2025-05-15
2024-12-31	$1,922,951	162,962	-5.6%	Shares	Defined	2025-02-14
2024-09-30	$3,561,355	172,630	+473.1%	Shares	Defined	2024-11-14
2024-06-30	$1,363,110	30,124	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.